AONC — American Oncology Network Balance Sheet
0.000.00%
Last trade - 00:00
- $50.01m
- $189.83m
- $1.28bn
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | |
Standards: | — | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | — | 27.4 | 36.8 | 63.9 |
Net Total Accounts Receivable | ||||
Net Total Receivables | — | 138 | 166 | 165 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | — | 208 | 242 | 278 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | — | 32.6 | 75.7 | 83.8 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | — | 248 | 326 | 374 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | — | 119 | 141 | 169 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | — | 189 | 264 | 471 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | — | 59.5 | 62 | -96.7 |
Total Liabilities & Shareholders' Equity | — | 248 | 326 | 374 |
Total Common Shares Outstanding | ||||
Total Preferred Shares Outstanding |